greedy pharma

Medicare and Medicaid cannot negotiate the cost of drugs – meaning they have to pay whatever a pharmaceutical company charges for their drugs.  This means that the potential for getting fleeced can be pretty high, including on the generic drugs which the public believes are cheaper. Some companies have been re-branding cheap medications that have been around for a while and then hiking up the price.  These sudden, sharp spikes in drug prices have led to a special Senate committee that deals with just this issue. 

Researchers from Oregon Health and Science University and School of Medicine analyzed one rather obscure drug, adrenocorticotropin, ACTH for short. The...